Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Impax Laboratories Inc.

    NASDAQ: IPXL · Real-Time Price · USD
    18.30
    0.00 (0.00%)
    At close: Jun 29, 2019, 12:07 AM

    Impax Laboratories Revenue Breakdown

    Period Ending Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
    Impax Generics Revenue 549.08M 606.32M 710.93M
    Impax Generics Revenue Growth -9.44% -14.71% n/a
    Impax Specialty Pharma Revenue 226.71M 218.11M 149.54M
    Impax Specialty Pharma Revenue Growth +3.94% +45.86% n/a

    Operating Expense Breakdown

    Period Ending Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
    Selling, General, and Administrative Revenue 142.86M 64.02M 53.59M 51.62M 47.05M 57.59M 55.04M 44.91M 44.3M 56.51M 46.31M 48.31M 50.16M
    Selling, General, and Administrative Revenue Growth +123.16% +19.47% +3.82% +9.69% -18.29% +4.63% +22.56% +1.38% -21.61% +22.04% -4.14% -3.69% n/a
    Research and Development Revenue 12.3M 202.42M 15.82M 26.85M 28.57M 43.78M 48.88M 21.75M 19.02M 26.39M 18.63M 17M 14.96M
    Research and Development Revenue Growth -93.93% +1179.44% -41.07% -6.02% -34.74% -10.45% +124.80% +14.32% -27.93% +41.67% +9.63% +13.59% n/a
    Sales and Marketing Revenue 85.54M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales and Marketing Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist